Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.57 Billion | USD 5.86 Billion | 15.80% | 2023 |
The global proton therapy market size was worth around USD 1.57 billion in 2023 and is predicted to grow to around USD 5.86 billion by 2032 with a compound annual growth rate (CAGR) of roughly 15.80% between 2024 and 2032.
Proton therapy is a novel method of treating cancers. This high-precision and advanced traditional treatment has proven beneficial in treating several types of tumors, especially the ones located in critical areas such as near the brain or the heart. Compared to other forms of cancer treatment, proton therapy involves the use of energy beams with greater intensity on the tumor itself and less traditional on healthy tissues or surrounding areas. Proton therapy is also known as beam therapy and leverages the intensity of protons to destroy tumor cells. In most cases, researchers suggest that proton therapy does not cause any pain, and patients can return to their daily lives after undergoing the treatment.
Generally, a course of proton therapy lasts for several weeks 5 days per week. Market research indicates that proton therapy allows medical professionals to deliver improved targeted radiation depending on the shape and size of the tumor. Proton therapy is used for several types of cancer, including liver cancer, brain tumors, rectal cancer, breast cancer, prostate cancer, sarcomas, eye cancer, and head & neck cancer. The demand for proton therapy is expected to grow due to the rising number of cancer patients across the globe. However, financial barriers and limited access to comprehensive medical reimbursements may impact the overall revenue.
Increasing awareness around cancer prevalence and early diagnosis to help drive the market demand rate
The global proton therapy market is expected to grow due to the rising awareness of cancer prevalence. In addition, healthcare companies are focusing on developing new tools for detecting cancer in its early stages, resulting in higher chances of treatment delivering positive results. In July 2024, the Biden Cancer Moonshot program hosted the White House Africa Cancer Forum. The initiative brought together 10 African nations to discuss cancer care in the region. The program led to the announcement of nearly USD 100 million toward improving cancer care initiatives in Africa.
In August 2024, the European Union Cancer Mission Bus Roadshow made its stop in Romania in the Brezoi region, thus marking the launch of a novel initiative to raise awareness about cancer prevention and treatment. In addition, efforts are being directed toward developing solutions that can help in early diagnosis of cancer. In October 2024, the Indian Institute of Technology (IIT) - Indore announced the launch of new affordable technology that can assist in early diagnosis of breast cancer. The tool leverages photoacoustic Spectral Response technology. The impact of proton therapy on cancer treatment can be significantly improved in case of diagnosis at early stages.
Rising investments in cancer research will generate higher market revenue in the coming years
Cancer prevention and treatment is one of the most extensively researched topics in the medical research industry. The growing prevalence of cancer and an urgent need to develop effective treatments have helped in creating higher investments in proton therapy. For instance, in September 2024, the Tata Memorial Center (TMC) announced the launch of a new in-house research project focusing on maximizing the use of proton beam therapy for cancer in adults and children.
Additionally, in a recent event, researchers at the Paul Scherrer Institute (PSI) worked on integrating a new workflow carefully designed every day depending on the size and location of the tumor. The team used the novel workflow in everyday clinical practice concerning proton therapy, which proved to be beneficial in delivering enhanced final results. The global proton therapy market can benefit from the increased investments in research initiatives.
Side effects associated with the treatment may limit the industry’s expansion rate
The global industry for proton therapy is projected to be limited due to the several associated side effects. Some of the most commonly unwanted effects of proton therapy include hair loss in the area of treatment, reddened or sore skin, which may appear as sunburn, and low energy or tiredness.
Additionally, side effects may also be reported depending on the treatment area, including problems with digestion or eating and headaches. The high cost of the treatment is an additional growth barrier, especially in countries with higher populations or low or middle-income groups.
Growing prevalence of cancer and greater demand for precision medicine will create growth opportunities
The global proton therapy market is expected to generate growth opportunities due to the rising prevalence of cancer cases worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of medically-caused deaths worldwide. In addition to this, the surge in the number of pediatric cancer cases has become a cause of concern. According to the Indian Cancer Society, more than 3 lakh children globally are diagnosed with cancer every year. Some cancer cases are more common as compared to others.
For instance, breast cancer is one of the most prevalent forms of the disease, affecting millions of women globally. The root cause of each type of cancer is difficult to determine. However, several cancers are often associated with specific risk factors. Some of the causes impacting the chances of brain cancer include exposure to radiation, age, genetic conditions, and weakened immune systems. In addition, cancer cells are always evolving, resulting in difficulty in diagnosing the condition at preliminary stages. In a large number of cases, cancer treatment remains ineffective, resulting in greater demand for precision therapy, which focuses on treating the tumor and neglecting the healthy tissues, thus avoiding compromising the immune system further.
Lack of access to the treatment and insurance coverage complexities to challenge the market expansion rate
The global proton therapy industry is expected to be challenged by the lack of access to efficient treatment facilities providing targeted therapy treatment. In addition to this, proton therapy may not be covered by insurance providers, especially in the absence of definitive proof that proton therapy is more effective than other forms of radiation therapy. Additionally, the therapy is not 100% effective in treating the condition, thus lacking large-scale adoption.
Report Attributes | Report Details |
---|---|
Report Name | Proton Therapy Market |
Market Size in 2023 | USD 1.57 Billion |
Market Forecast in 2032 | USD 5.86 Billion |
Growth Rate | CAGR of 15.80% |
Number of Pages | 220 |
Key Companies Covered | Google Cloud Platform (GCP Security), Palo Alto Networks, McAfee (MVISION Cloud), Akamai, Microsoft (Azure Security), Fortinet, Check Point Software, Proofpoint, Amazon Web Services (AWS Security), Trend Micro, Cisco, Tenable, CrowdStrike, Qualys, Zscaler, and others. |
Segments Covered | By Type, By Product Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global proton therapy market is segmented based on type, product type, and region.
Based on the type, the global market segments are multi-room systems and single-room systems. In 2023, the highest growth was witnessed in the multi-room systems segment. In 2023, it held control over 67.45% of the total revenue. The system is equipped to generate photon beams that can be directed toward several rooms simultaneously, thus allowing more patients to receive the treatment. Furthermore, the process is not only time-saving but also prevents resources from being overexploited.
Based on the product type, the proton therapy industry divisions are services and equipment. In 2023, according to market research, around 87.01% of the segmental share was dominated by the equipment segment. Photon therapy machines and tools are highly advanced solutions built with sophisticated technologies. The complexity also increases the cost of the equipment resulting in greater revenue. Increased research on photon therapy will fuel higher revenue in the industry.
North America to account for the highest share in total revenue during the forecast period
The global proton therapy market will be led by North America during the forecast period. According to market research, the region held control over 45% of the global revenue in 2023, driven by the presence of a robust and highly evolved cancer care industry. Awareness around the disease and effective treatments across the US and Canada remain unmatched. Additionally, the surging investments in cancer research, including photon therapy, will further promote higher regional revenue during the projection period.
In June 2024, researchers at The University of Texas released the reports of a novel multi-institution Phase III trial. In the preliminary data, the scientists claimed that photon therapy had shown significant results in treating head and neck cancer. The treatment also produced a limited number of side effects. The regional market players are also working on some of the key challenges faced by proton therapy seekers in the country. For instance, a study published in the JAMA Network Open highlighted the concerns about travel time for accessing proton therapy. Such studies will direct attention toward solving the issues that the regional population faces in undergoing the treatment.
The global proton therapy market is led by players like:
By Type
By Product Type
FrequentlyAsked Questions
Proton therapy is a novel method of treating cancers.
The global proton therapy market is expected to grow due to the rising awareness of cancer prevalence.
According to study, the global proton therapy market size was worth around USD 1.57 billion in 2023 and is predicted to grow to around USD 5.86 billion by 2032.
The CAGR value of the proton therapy market is expected to be around 15.80% during 2024-2032.
The global proton therapy market will be led by North America during the forecast period.
The global proton therapy market is led by players like Google Cloud Platform (GCP Security), Palo Alto Networks, McAfee (MVISION Cloud), Akamai, Microsoft (Azure Security), Fortinet, Check Point Software, Proofpoint, Amazon Web Services (AWS Security), Trend Micro, Cisco, Tenable, CrowdStrike, Qualys, and Zscaler.
The report explores crucial aspects of the proton therapy market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed